vimarsana.com

Page 66 - கதிர்வீச்சு புற்றுநோயியல் நிபுணர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Oncora Medical to power Mass General s Pediatric Proton/Photon Consortium Registry to fight pediatric cancer with data

Oncora Medical to power Mass General s Pediatric Proton/Photon Consortium Registry to fight pediatric cancer with data News provided by Share this article Share this article BOSTON, Mass. and PHILADELPHIA, Pa., Dec. 22, 2020 /PRNewswire/ Oncora Medical, an oncology data and software company, has been selected to power the Pediatric Proton/Photon Consortium Registry (PPCR), run out of the Mass General Cancer Center  (MGCC), with their Oncora Analytics software platform. The PPCR is a consented registry for pediatric cancer patients with the goal of enabling more rapid research into the impact of advanced treatments such as proton therapy on children suffering from cancer. The current list of participating cancer centers includes many of the top centers in the US such as MD Anderson, the University of Pennsylvania, Northwestern Chicago Proton Center, Washington University, and the University of Florida.

Search committee formed to identify next Hopkins Nursing dean

Search committee formed to identify next Hopkins Nursing dean The school s new leader will succeed Patricia Davidson, who has led the School of Nursing since 2013 By Hub staff report / Published Dec 21, 2020 Johns Hopkins University today announced plans to launch a global search for the next dean of its School of Nursing. Patricia Davidson, a global leader in cardiac health and the care of vulnerable populations, will leave the university in April to become vice-chancellor of the University of Wollongong in her native Australia. These achievements, as well as countless others, reflect the tireless work of Trish and the school s outstanding faculty, staff, and students, to increase the impact of Hopkins Nursing and extend its reach around the globe, JHU President Ronald J. Daniels wrote in a message to the Hopkins community today. We are in a fortunate position to be able to build upon this great foundation as we search the right p

Single-Dose Radiation Therapy Can Counteract Serious Breast Cancer Treatment Compliance Issues During Pandemic

Single-Dose Radiation Therapy Can Counteract Serious Breast Cancer Treatment Compliance Issues During Pandemic Targeted Intraoperative Radiotherapy or TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 6-week radiotherapy, significantly reducing COVID-19 risk to patients Image courtesy of Zeiss December 21, 2020   According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens. However, physicians at Mercy Medical Center are countering this trend with a procedure called Targeted Intraoperative Radiotherapy, or TARGIT-IORT using the Intrabeam System from ZEISS. Mercy was the first hospital in Maryland to acquire the INTRABEAM Radiotherapy System in 2012, and remains the only hospital in the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.